BlackRock Health Sciences Term Trust (BMEZ) To Go Ex-Dividend on June 15th

BlackRock Health Sciences Term Trust (NYSE:BMEZ) declared a monthly dividend on Friday, February 27th. Stockholders of record on Monday, June 15th will be paid a dividend of 0.11 per share on Tuesday, June 30th. This represents a c) dividend on an annualized basis and a dividend yield of 9.1%. The ex-dividend date is Monday, June 15th.

BlackRock Health Sciences Term Trust Stock Performance

Shares of BMEZ stock traded up $0.08 on Friday, reaching $14.52. 131,866 shares of the company’s stock traded hands, compared to its average volume of 240,027. BlackRock Health Sciences Term Trust has a 12-month low of $13.67 and a 12-month high of $15.80. The business’s 50 day moving average price is $14.29 and its two-hundred day moving average price is $14.74.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Kestra Advisory Services LLC purchased a new position in shares of BlackRock Health Sciences Term Trust during the fourth quarter valued at $26,000. SouthState Bank Corp purchased a new position in shares of BlackRock Health Sciences Term Trust during the first quarter valued at $29,000. PNC Financial Services Group Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust during the first quarter valued at $35,000. Geneos Wealth Management Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust during the first quarter valued at $40,000. Finally, Allworth Financial LP grew its holdings in shares of BlackRock Health Sciences Term Trust by 24,584.6% during the third quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock valued at $46,000 after buying an additional 3,196 shares in the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.